- Home
- ADAP vs AKYA Comparison
ADAP vs AKYA Comparison
Compare ADAP & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- AKYA
- Stock Information
- Founded
- ADAP 2008
- AKYA 2015
- Country
- ADAP United Kingdom
- AKYA United States
- Employees
- ADAP N/A
- AKYA N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- AKYA Medical Specialities
- Sector
- ADAP Health Care
- AKYA Industrials
- Exchange
- ADAP Nasdaq
- AKYA Nasdaq
- Market Cap
- ADAP 71.6M
- AKYA 84.7M
- IPO Year
- ADAP 2015
- AKYA 2021
- Fundamental
- Price
- ADAP $0.21
- AKYA $1.43
- Analyst Decision
- ADAP Strong Buy
- AKYA Buy
- Analyst Count
- ADAP 5
- AKYA 7
- Target Price
- ADAP $1.93
- AKYA $3.26
- AVG Volume (30 Days)
- ADAP 2.4M
- AKYA 279.7K
- Earning Date
- ADAP 03-20-2025
- AKYA 03-17-2025
- Dividend Yield
- ADAP N/A
- AKYA N/A
- EPS Growth
- ADAP N/A
- AKYA N/A
- EPS
- ADAP N/A
- AKYA N/A
- Revenue
- ADAP $178,032,000.00
- AKYA $81,672,000.00
- Revenue This Year
- ADAP N/A
- AKYA $14.38
- Revenue Next Year
- ADAP $56.87
- AKYA $15.03
- P/E Ratio
- ADAP N/A
- AKYA N/A
- Revenue Growth
- ADAP 195.34
- AKYA N/A
- 52 Week Low
- ADAP $0.20
- AKYA $1.39
- 52 Week High
- ADAP $1.55
- AKYA $4.69
- Technical
- Relative Strength Index (RSI)
- ADAP 14.09
- AKYA 32.48
- Support Level
- ADAP $0.26
- AKYA $1.39
- Resistance Level
- ADAP $0.47
- AKYA $1.78
- Average True Range (ATR)
- ADAP 0.04
- AKYA 0.14
- MACD
- ADAP -0.02
- AKYA 0.02
- Stochastic Oscillator
- ADAP 1.23
- AKYA 11.39
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.